Featured Article
Category: News
Anti-VEGF Drug Showing Promise for Diabetic Macular Edema
In a phase II study of patients with diabetic macular edema (DME), intravitreal injections of a fusion protein called VEGF Trap-Eye proved superior to focal/grid laser treatment, researchers report. Reuters Health Information
Retinal Signs in Older Patients Portend Future Disability
A link has been found between retinal microvascular signs and functional disability in older adults. Medscape Medical News
Researchers Develop 3D Sensing Wheelchair for the Visually Impaired
Researchers from Luleå University of Technology in Sweden are developing a wheelchair that senses its environment in 3D and transmits this information to its user. It features a laser scanner that uses a time-of-flight technique to map its surroundings in 3D. A haptic robot, held in the left hand, translates this data to useful information for the user, enabling one to feel obstacles, essentially acting as a virtual white cane. A joystick is used with the right hand for steering.
Merck acquires Inspire Pharmaceuticals
Merck, known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing ophthalmic products, for $…
Crystalens Post-LASIK
Featured Article
When and Where to YAG Crystalens IOLs
Featured Article
Challenging Crystalens Cases in 3D Cases
Featured Article
pSivida Announces Resubmission Of New Drug Application For ILUVIEN(R)
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the in…
pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIE…
Ultrasound Vs. Optical Biometry
Technology Spotlight
SD-OCT Shows Variations Of Choroidal Thickness
Spectral domain optical coherence tomography shows that choroidal thickness is not uniform around the ocular globe and is significantly reduced in highly myopic eyes, according to a study presented here. Gabriel Coscas, MD, spoke about spectral domain …
Eye Injury Visits More Common in Rural Areas
(MedPage Today) — Rural patients were five times more likely than their urban counterparts to visit a hospital emergency department with an eye injury, federal researchers reported.
Scientists For The First Time Regenerate Sections Of Retinas And Increase Visual Function With Stem Cells Derived From Skin
Scientists from Schepens Eye Research Institute are the first to regenerate large areas of damaged retinas and improve visual function using IPS cells (induced pluripotent stem cells) derived from skin…
Stroke Survivors Recovering Lost Vision With Non-Invasive Light Therapy
Statistics show that stroke is a leading cause of serious long-term disability and, although each person is unique, stroke can affect people similarly with comparable disabilities such as partial blindness due to visual field loss – a condition previou…
More Rural Americans Are Treated In Emergency Departments For Eye Injuries
AHRQ News and Numbers: More Rural Americans treated in emergency departments for eye injuries. Rural Americans were five times more likely than urban residents to be treated in emergency departments for eye injuries in 2008, according to the latest New…
More Rural Americans Are Treated In Emergency Departments For Eye Injuries
AHRQ News and Numbers: More Rural Americans treated in emergency departments for eye injuries. Rural Americans were five times more likely than urban residents to be treated in emergency departments for eye injuries in 2008, according to the latest New…
HEALTHY VISION MONTH, MAY 2011
During Healthy Vision Month, the National Eye Institute (NEI), part of the National Institutes of Health, encourages people and organizations around the world to recognize the value of the sense of sight and make vision health a priority.
HEALTHY VISION MONTH, MAY 2011
During Healthy Vision Month, the National Eye Institute (NEI), part of the National Institutes of Health, encourages people and organizations around the world to recognize the value of the sense of sight and make vision health a priority.
Ranibizumab And Bevacizumab Have Equivalent Effect On Neovascular AMD
Two of the most commonly used treatments for neovascular age-related macular degeneration (AMD), ranibizumab (Lucentis, Genentech), approved in 2006 by FDA, and the other commonly used ‘off-label,’ bevacizumab (Avastin, Genentech), resulted in similar …